Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q4 2022 vs. Q3 2022
How the institutions holding Alterity Therapeutics Ltd changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 9 | 13 | +4 |
| Shares | 676.8K | 662.1K | −14.6K (−2.2%) |
| Value | $299.0K | $230.5K | −$68.5K (−22.9%) |
New holders (7)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Mission Capital LLC | 36,093 | $12.6K | 0.00% |
| BNP Paribas Arbitrage, SA | 700 | $244 | 0.00% |
| The PNC Financial Services Group, Inc. | 400 | $140 | 0.00% |
| CoreCap Advisors, LLC | 216 | $75 | 0.00% |
| Coppell Advisory Solutions LLC | 149 | $52 | 0.00% |
| Coppell Advisory Solutions Corp. | 149 | $52 | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Envestnet Asset Management Inc | 78,065 | $35.0K |
| Two Sigma Securities, LLC | 23,190 | $10.0K |
| Geode Capital Management, LLC | 12,128 | $5.00K |